ENZYVANT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ENZYVANT Trademark

Serial Number: 88361384 • Registration: 6077704

ENZYVANT is a trademark filed by Enzyvant Therapeutics GmbH on March 28, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Enzyvant Therapeutics GmbH (11 trademarks)

Viaduktstrasse 8
Basel 4051 , CH

Entity Type: 99

Trademark Details

Filing Date

March 28, 2019

Registration Date

June 16, 2020

Published for Opposition

March 31, 2020

Goods & Services

Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto

(Based on 44(e)) Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 16, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Feb 27, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 7, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 26, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 25, 2020 GNFN
FINAL REFUSAL E-MAILED
Jan 25, 2020 GNFR
FINAL REFUSAL WRITTEN
Jan 25, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2019 TROA
ASSIGNED TO EXAMINER
Jul 25, 2019 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2019 CNRT
ASSIGNED TO EXAMINER
May 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2019 NWOS
NEW APPLICATION ENTERED
Apr 1, 2019 NWAP